Advanced search
Publication Cover
Journal of Medical Economics Volume 21, 2018 - Issue 5
Submit an article Journal homepage
709
Views
10
CrossRef citations to date
0
Altmetric
Infectious Disease

A best–worst scaling in Colombian patients to rank the characteristics of HIV/AIDS treatment

A. HendriksDepartment of Health Services Research, CAPHRI Care and Public Research Institute, Maastricht University, Maastricht, The Netherlands;
,
B. WijnenDepartment of Health Services Research, CAPHRI Care and Public Research Institute, Maastricht University, Maastricht, The Netherlands;
,
R. van EngelenDepartment of Health Services Research, CAPHRI Care and Public Research Institute, Maastricht University, Maastricht, The Netherlands;
,
R. CondeAsistencia Cientifica de Alta Complejidad, Bogotá, Colombia; ;Universidad del Rosario, Bogotá, Colombia;
,
S.M. EversDepartment of Health Services Research, CAPHRI Care and Public Research Institute, Maastricht University, Maastricht, The Netherlands; ORCID Iconhttp://orcid.org/0000-0003-1026-570X
ORCID Icon,
J. GonzalezUniversidad del Rosario, Bogotá, Colombia;
,
M. GoversDepartment of Health Services Research, CAPHRI Care and Public Research Institute, Maastricht University, Maastricht, The Netherlands;
,
A. MühlbacherHochschule Neubrandenburg, Neubrandenburg, Germany
&
M. HiligsmannDepartment of Health Services Research, CAPHRI Care and Public Research Institute, Maastricht University, Maastricht, The Netherlands; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0003-4274-9258
ORCID Icon show all
Pages 468-473 | Received 17 Feb 2017, Accepted 10 Feb 2018, Published online: 26 Feb 2018

References

  • UNAIDS. UNAIDS Global report. UNAIDS; 2013
  • WHO. People living with HIV (all ages). WHO; 2010
  • Murray CJ, Ortblad KF, Guinovart C, et al. Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014;384:1005-70
  • Mills EJ, Nachega JB, Buchan I, et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA 2006;296:679-90
  • Clark MD, Determann D, Petro S, et al. Discrete choice experiments in health economics: a review of the literature. PharmacoEconomics 2014;32:883-902
  • Lancsar E, Louviere J. Conducting discrete choice experiments to inform healthcare decision making. PharmacoEconomics 2008;26:661-77
  • Cheung KL, Wijnen BF, Hollin IL, et al. Using best–worst scaling to investigate preferences in health care. PharmacoEconomics 2016;34:1195-209
  • Gazzard B, Ali S, Muhlbacher A, et al. Patient preferences for characteristics of antiretroviral therapies: results from 5 European countries. J Int AIDS Soc 2014 Nov 2;17(4 Suppl 3):19540
  • Youngkong S, Baltussen R, Tantivess S, et al. Criteria for priority setting of HIV/AIDS interventions in Thailand: a discrete choice experiment. BMC Health Serv Res 2010;10:1
  • Terris-Prestholt F, Hanson K, MacPhail C, et al. How much demand for new HIV prevention technologies can we really expect? Results from a discrete choice experiment in South Africa. PLoS One 2013;8:e83193
  • Mühlbacher AC, Stoll M, Mahlich J, et al. Patient preferences for HIV/AIDS therapy – a discrete choice experiment. Health Econ Rev 2013 May 11;3(1):14
  • Finn A, Louviere JJ. Determining the appropriate response to evidence of public concern: the case of food safety. J Public Policy Market 1992;11:12-25
  • Muhlbacher AC, Zweifel P, Kaczynski A, et al. Experimental measurement of preferences in health care using best-worst scaling (BWS): theoretical and statistical issues. Health Econom Rev 2016;6:5
  • Situación del VIH en Colombia 2015 – Cuenta de Alto Costo. http://cuentadealtocosto.org/site/images/Publicaciones/Situación%20del%20VIH%20en%20Colombia%202015.pdf
  • Kremer IE, Evers SM, Jongen PJ, et al. Identification and prioritization of important attributes of disease-modifying drugs in decision making among patients with multiple sclerosis: a nominal group technique and best–worst scaling. PLoS One 2016;11:e0164862
  • Hiligsmann M, Dellaert B, Dirksen C, et al. Patients’ preferences for anti-osteoporosis drug treatment: a cross-European discrete-choice experiment. Rheumatology 2017;56:1167-76
  • Hifinger M, Hiligsmann M, Ramiro S, et al. Economic considerations and patients’ preferences affect treatment selection for rheumatoid arthritis patients: a discrete choice experiment among European rheumatologists. Ann Rheum Dis 2017;76:126-32
  • Cheung KL, Evers SMAA, De Vries H, et al. Most important barriers and facilitators of HTA usage in decision-making in Europe. Expert Rev Pharmacoecon Outcomes Res 2018 Jan 5:1-8. doi: 10.1080/14737167.2018.1421459. [Epub ahead of print]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.